Table 3.
Univariate and multivariate analyses of clinicopathological parameters for OS.
| Factor | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| P | HR (95%CL) | P | HR (95%CL) | |
|
Age
>60 ≤60 |
0.034 | 1.245(1.015-1.526) | 0.047 | 1.230(1.003-1.508) |
|
LN Metastasis
>2 ≤2 |
<0.001 | 1.474(1.186-1.843) | 0.022 | 1.314(1.040-1.658) |
|
Pathological stage
IIIa IIb |
<0.001 | 1.684(1.337-2.120) | <0.001 | 1.629(1.272-2.088) |
|
Gender
Male Female |
0.011 | 1.299(1.060-1.590) | 0.137 | 1.170(0.951-1.439) |
|
Surgical Method
Open VATS |
0.158 | 1.252(0.916-1.712) | ||
|
Air dissemination
Yes No |
0.113 | 0.857(0.699-1.049) | ||
|
Vascular invasion
Yes No |
0.935 | 0.992(0.810-1.214) | ||
|
Chemotherapy
Yes No |
0.013 | 1.324(1.060-1.655) | 0.613 | 1.065(0.835-1.357) |
|
Targeted therapy
Yes No |
<0.001 | 0.565 (0.458-0.696) | <0.001 | 0.531(0.430-0.655) |
|
Radiotherapy
Yes No |
0.232 | 0.861(0.674-1.101) | ||
| Immunotherapy | ||||
| Yes | 0.303 | 1.161(0.874-1.543) | ||
| No | ||||
Bold means P < 0.001 was considered very significant.